{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:47:37Z","timestamp":1793353657634,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jhep.2020.12.004","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T01:30:07Z","timestamp":1607995807000},"page":"1286-1294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis"],"prefix":"10.1016","volume":"74","author":[{"given":"Anton L.V.","family":"Avance\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0460-0014","authenticated-orcid":false,"given":"Nicholas","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-5873","authenticated-orcid":false,"given":"Sarah E.","family":"Uttal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9677-1632","authenticated-orcid":false,"given":"David W.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Mellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.12.004_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMra1715733","article-title":"Alcohol use in patients with chronic liver disease","volume":"379","author":"Fuster","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.12.004_bib2","doi-asserted-by":"crossref","first-page":"i124","DOI":"10.1136\/bmj.i124","article-title":"Decompensated alcohol related liver disease: acute management","volume":"352","author":"McPherson","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2020.12.004_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2020.12.004_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2020.12.004_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhep.2020.12.004_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/hepr.12131","article-title":"Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: a systematic review and meta-analysis","volume":"44","author":"Xie","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2020.12.004_bib7","series-title":"Medication for the treatment of alcohol use disorder: a brief guide","year":"2015"},{"key":"10.1016\/j.jhep.2020.12.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13311-019-00802-8","article-title":"Diagnosis and management of alcohol use disorder in patients with liver disease: lights and shadows","volume":"17","author":"Addolorato","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jhep.2020.12.004_bib10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.jhep.2020.12.004_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-related liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.004_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.12.004_bib13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease","volume":"65","author":"Addolorato","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/acer.13944","article-title":"Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis","volume":"43","author":"Mellinger","year":"2019","journal-title":"Alcohol Clin Exp Re"},{"key":"10.1016\/j.jhep.2020.12.004_bib15","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis","volume":"71","author":"Rogal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.004_bib16","series-title":"Cost-effectiveness in health and medicine","year":"2017"},{"key":"10.1016\/j.jhep.2020.12.004_bib17","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.05.043","article-title":"Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis","author":"Jepsen","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","article-title":"Natural history of histologically proven alcohol-related liver disease: a systematic review","volume":"71","author":"Parker","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/TP.0000000000002843","article-title":"Gender disparities in patients with alcoholic liver disease evaluated for liver transplantation","volume":"104","author":"McElroy","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2020.12.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.06.019","article-title":"Patients with hepatocellular carcinoma have highest rates of wait-listing for liver transplantation among patients with end-stage liver disease","volume":"14","author":"Goldberg","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajt.15674","article-title":"OPTN\/SRTR 2018 annual data report: liver","volume":"20","author":"Kwong","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2020.12.004_bib23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpsyc.65.10.1214","article-title":"Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients","volume":"65","author":"Zarkin","year":"2008","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.jhep.2020.12.004_bib24","series-title":"Pharmaceutical prices","year":"2020"},{"key":"10.1016\/j.jhep.2020.12.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.02.001","article-title":"Cost-effectiveness of individual versus group female-specific cognitive behavioral therapy for alcohol use disorder","volume":"100","author":"Olmstead","year":"2019","journal-title":"J\u00a0Substance Abuse Treat"},{"key":"10.1016\/j.jhep.2020.12.004_bib26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.28961","article-title":"Early detection and curative treatment of hepatocellular carcinoma: a cost-effectiveness analysis in France and in the United States","volume":"65","author":"Cadier","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.004_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.07.024","article-title":"Healthcare costs related to treatment of hepatocellular carcinoma among veterans with cirrhosis in the United States","volume":"16","author":"Kaplan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.alcohol.2018.02.003","article-title":"Mortality and costs associated with alcoholic hepatitis: a claims analysis of a commercially insured population","volume":"71","author":"Thompson","year":"2018","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2020.12.004_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0272989X08315240","article-title":"Health-state utilities in liver disease: a systematic review","volume":"28","author":"McLernon","year":"2008","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jhep.2020.12.004_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/jlts.2002.31345","article-title":"Assessing health-related quality of life pre\u2013 and post\u2013liver transplantation: a prospective multicenter study","volume":"8","author":"Ratcliffe","year":"2002","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhep.2020.12.004_bib31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States","volume":"68","author":"Mellinger","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.004_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ajt.14559","article-title":"OPTN\/SRTR 2016 annual data report: liver","volume":"18","author":"Kim","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2020.12.004_bib33","first-page":"2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE Study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"Yearb Psychiatr Appl Ment Health"},{"key":"10.1016\/j.jhep.2020.12.004_bib34","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.12.004_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: the basics","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value in Health"},{"key":"10.1016\/j.jhep.2020.12.004_bib36","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"QALYs in 2018 \u2013 advantages and concerns","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.12.004_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?","volume":"46","author":"Braithwaite","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.jhep.2020.12.004_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis","volume":"29","author":"Rehm","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.jhep.2020.12.004_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1377\/hlthaff.2016.0098","article-title":"Access to mental health care increased but not for substance use, while disparities remain","volume":"35","author":"Creedon","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.jhep.2020.12.004_bib40","first-page":"23","article-title":"Preventing drinking relapse in patients with alcoholic liver disease","volume":"14","author":"Winder","year":"2015","journal-title":"Curr Psychiatr"},{"key":"10.1016\/j.jhep.2020.12.004_bib41","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2020.12.004_bib42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/lt.25641","article-title":"Integration of an addiction team in a liver transplantation center","volume":"25","author":"Donnadieu-Rigole","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.12.004_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the epidemiologic survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jhep.2020.12.004_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MLR.0b013e3181ca3d40","article-title":"Revisiting the cost-effectiveness of the COMBINE Study for alcohol dependent patients: the patient perspective","volume":"48","author":"Dunlap","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jhep.2020.12.004_bib45","series-title":"Cost-effectiveness in Health and Medicine","first-page":"385","article-title":"Appendix A: worked example: the cost-Eefectiveness of treatments for individuals with alcohol use disorders: a reference case analysis","author":"Kim","year":"2017"},{"key":"10.1016\/j.jhep.2020.12.004_bib46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0168-8278(97)80355-8","article-title":"Effect of liver cirrhosis on the systemic availability of naltrexone in humans","volume":"27","author":"Bertolotti","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.004_bib47","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:40:33Z","timestamp":1759174833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820338411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0168827820338411"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.12.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}